CAR T-Cells: Building Better Cancer Immunotherapy by Leveraging Molecular & Computational Tools to Understand Living Drugs
Can we define a limited set of markers we can use very inexpensively and reproducibly, to continually monitor our production of new drugs, and identify from a drop of patient's blood, before we manufacture their cells in that expensive process? Mark Bonyhadi foresees a future in which CAR T-Cells unlock that possibility.
Tags
Ready to Drive Life Sciences Forward?
Experience the transformative power of Klick Health, where deep industry expertise meets cutting-edge AI-driven wisdom.
As your trusted partners in life sciences commercialization, we combine a storied history in healthcare with the latest technologies to elevate every facet of your omnichannel strategy. From crafting engaging narratives to enabling data-driven decision-making, our integrated capabilities ensure you lead the way in transforming patient outcomes through digital health innovation.
Let’s create something transformative together.
